Assertio Holdings (ASRT) Investor Presentation August 2022

Assertio is a commercial pharmaceutical company focused on differentiated specialty products in neurology, hospital, and pain/inflammation. The company has executed a significant restructuring to improve profitability and reposition for future growth, with 1H 2022 revenues of $71.7M and 2022 FY guidance of $129-137M.